Sisters Advocate for Awareness After Rare Heart Disease Diagnosis
Megan Kaverman and her sister Katie Gusching have become advocates for pulmonary arterial hypertension (PAH) after both were diagnosed with the rare genetic disorder. Kaverman, diagnosed at 27, experienced symptoms like shortness of breath and fatigue for years before receiving a diagnosis. Her sister, Gusching, noticed similar symptoms and was diagnosed two years later. PAH is a condition where mutations cause the small arteries in the lungs to narrow, increasing blood pressure and straining the heart. The sisters receive treatment at the Cleveland Clinic and participate in clinical trials to explore new care options. 
